193 related articles for article (PubMed ID: 30963622)
1. Expression of miR-486-5p and its significance in lung squamous cell carcinoma.
Yang S; Sui J; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
J Cell Biochem; 2019 Aug; 120(8):13912-13923. PubMed ID: 30963622
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
[TBL] [Abstract][Full Text] [Related]
4. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
[TBL] [Abstract][Full Text] [Related]
5. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis.
Ye P; Lv X; Aizemaiti R; Cheng J; Xia P; Di M
Cell Prolif; 2020 May; 53(5):e12797. PubMed ID: 32297697
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-125b-5p and Its Prospective Molecular Mechanism in Lung Squamous Cell Carcinoma.
Huang SP; Jiang YF; Yang LJ; Yang J; Liang MT; Zhou HF; Luo J; Yang DP; Mo WJ; Chen G; Shi L; Gan TQ
Cancer Biother Radiopharm; 2022 Mar; 37(2):125-140. PubMed ID: 32614608
[No Abstract] [Full Text] [Related]
7. miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells.
Lu Y
Comput Math Methods Med; 2021; 2021():6248793. PubMed ID: 34306176
[TBL] [Abstract][Full Text] [Related]
8. Clinical Value and Potential Mechanism of miRNA-33a-5p in Lung Squamous Cell Carcinoma.
Wang XM; Chen SW; Chen G; Zhou HF; Gan TQ; Zeng JJ; Li ZY
Anal Cell Pathol (Amst); 2021; 2021():6614331. PubMed ID: 34888137
[TBL] [Abstract][Full Text] [Related]
9. Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma.
Chen WJ; Gan TQ; Qin H; Huang SN; Yang LH; Fang YY; Li ZY; Pan LJ; Chen G
Pathol Res Pract; 2017 Apr; 213(4):364-372. PubMed ID: 28214218
[TBL] [Abstract][Full Text] [Related]
10. MiR-30a-5p hampers proliferation of lung squamous cell carcinoma through targeting FBXO45.
Zeng F; You S; Dai X
Histol Histopathol; 2022 May; 37(5):483-492. PubMed ID: 35098525
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of high expression of miR-452-5p in lung squamous cell carcinoma.
Gan XN; Gan TQ; He RQ; Luo J; Tang RX; Wang HL; Zhou H; Qing H; Ma J; Hu XH; Chen G
Oncol Lett; 2018 May; 15(5):6418-6430. PubMed ID: 29616113
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
Yu H; Pang Z; Li G; Gu T
J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
[TBL] [Abstract][Full Text] [Related]
13. MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.
Zhou Y; Yan J; Chen H; Zhou W; Xiao G; Zou H; Yang J
Appl Biochem Biotechnol; 2022 Jul; 194(7):3031-3043. PubMed ID: 35334070
[TBL] [Abstract][Full Text] [Related]
14. LINC01232 promotes lung squamous cell carcinoma progression through modulating miR-181a-5p/SMAD2 axis.
Zhang D; Hua M; Zhang N
Am J Med Sci; 2023 Apr; 365(4):386-395. PubMed ID: 36543302
[TBL] [Abstract][Full Text] [Related]
15. Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progression.
Zhao Z; Li H; Li J; Rong Y; Zhao L; Hao M; Tian F
J Cardiothorac Surg; 2024 Apr; 19(1):222. PubMed ID: 38627774
[TBL] [Abstract][Full Text] [Related]
16. CircTIMELESS regulates the proliferation and invasion of lung squamous cell carcinoma cells via the miR-136-5p/ROCK1 axis.
Zhang W; Shi J; Cheng C; Wang H
J Cell Physiol; 2020 Sep; 235(9):5962-5971. PubMed ID: 31960961
[TBL] [Abstract][Full Text] [Related]
17. miR-30a-5p suppresses lung squamous cell carcinoma via ATG5 - mediated autophagy.
Yang J; Rao S; Cao R; Xiao S; Cui X; Ye L
Aging (Albany NY); 2021 Jul; 13(13):17462-17472. PubMed ID: 34253689
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Ke D; Guo Q; Fan TY; Xiao X
Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
[No Abstract] [Full Text] [Related]
19. Identification of high expression profiles of miR-31-5p and its vital role in lung squamous cell carcinoma: a survey based on qRT-PCR and bioinformatics analysis.
Chi XJ; Wei LL; Bu Q; Mo N; Chen XY; Lan D; Zhou QN
Transl Cancer Res; 2019 Jun; 8(3):788-801. PubMed ID: 35116817
[TBL] [Abstract][Full Text] [Related]
20. MiR-497-5p down-regulates CDCA4 to restrains lung squamous cell carcinoma progression.
Hu J; Xiang X; Guan W; Lou W; He J; Chen J; Fu Y; Lou G
J Cardiothorac Surg; 2021 Nov; 16(1):330. PubMed ID: 34772428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]